African Americans with diabetes are less likely than whites to be treated with lipid-lowering agents, have their medication altered, or reach LDL-C goal.
Manel Pladevall, MD, MS
Advertisement
Articles by Manel Pladevall, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
2
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5